(In thousands)
|
For the Three Months
Ended June 30, |
For the Six Months
Ended June 30, | |||||||||||||||
| 2022 | 2021 | 2022 | 2021 | |||||||||||||
| Adjusted EBITDA: | ||||||||||||||||
| Net loss | $ | (16,549 | ) | $ | (12,264 | ) | $ | (36,544 | ) | $ | (22,765 | ) | ||||
| Add (deduct): | ||||||||||||||||
| Interest expense, interest and dividend income and other expenses | 1,217 | 463 | 2,852 | 916 | ||||||||||||
| Depreciation and amortization expense(1) | 2,008 | 753 | 3,807 | 1,487 | ||||||||||||
| Income tax benefit | — | — | (559 | ) | — | |||||||||||
| Amortization of lease intangible | 333 | — | 666 | — | ||||||||||||
| Stock-based compensation( 2) | 5,479 | 1,975 | 8,935 | 2,480 | ||||||||||||
| Charitable contribution of common stock | 1,285 | — | 1,285 | — | ||||||||||||
| Income from unconsolidated joint venture | (269 | ) | — | (303 | ) | — | ||||||||||
| Acquisition and other ( 3) | (1,923 | ) | — | (1,284 | ) | — | ||||||||||
| Impairment of long-lived assets | 119 | — | 119 | — | ||||||||||||
| Adjusted EBITDA | $ | (8,300 | ) | $ | (9,073 | ) | $ | (21,026 | ) | $ | (17,882 | ) | ||||
